AbbVie Inc. up 3.29% — Zacks reports

• •Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
• •Where Will AbbVie Be in 5 Years?
• •Broad market: S&P 500: -0.4%, Nasdaq: -0.9%, Dow Jones: -1.1%, Shanghai: +0.4%, Hang Seng: +0.9%, Nikkei 225: +0.2%, FTSE 100: +0.6%, Nifty 50: -1.2%, DAX: -0.0%, OMX Stockholm: +0.5%

AbbVie Inc. (ABBV) is trading notably up, at $232.08 — up 3.29% from yesterday's close of $224.69. Recent news includes "Why AbbVie (ABBV) is a Top Value Stock for the Long-Term" and "Where Will AbbVie Be in 5 Years?". The broader market is under pressure (S&P 500: -0.4%, Nasdaq: -0.9%, Dow Jones: -1.1%, Shanghai: +0.4%, Hang Seng: +0.9%, Nikkei 225: +0.2%, FTSE 100: +0.6%, Nifty 50: -1.2%, DAX: -0.0%, OMX Stockholm: +0.5%). Past performance does not guarantee future results.

Auto-generated · less than a minute ago